APA (7th ed.) Citation

M, M., D, M., E, R., V, M., E, M., A, G., . . . A, P. (2020). Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? Frontiers in oncology, 10, 595838. https://doi.org/10.3389/fonc.2020.595838

Chicago Style (17th ed.) Citation

M, Mariani, et al. "Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?" Frontiers in Oncology 10 (2020): 595838. https://doi.org/10.3389/fonc.2020.595838.

MLA (9th ed.) Citation

M, Mariani, et al. "Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?" Frontiers in Oncology, vol. 10, 2020, p. 595838, https://doi.org/10.3389/fonc.2020.595838.